MedTrace Logo

Education Impact on Rehabilitation of Hospitalized Patients with Chronic Obstructive Pulmonary Disease.

NCT06028711 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-10-29

No results posted yet for this study

Summary

The planned research will enable the assessment of rehabilitation's effects using two pulmonary rehabilitation models: conventional and supplemented with an education program for patients hospitalized due to chronic obstructive pulmonary disease.

Conditions

Interventions

OTHER

Education program

Patients in a study group will participate in daily education program using an original brochure containing information on the benefits of appropriately adapted physical activity, practical tips on airway clearance techniques or physical exercise, and risk factors for exacerbation of COPD.

OTHER

Pulmonary rehabilitation

The patients will participate in a 14-day rehabilitation program (Monday to Saturday). Treatments and therapies will be continued for a maximum of two hours daily. The program will be applied individually to each patient and include active and assisted exercises, effective cough exercises, pursed-lips breathing, positive expiratory pressure exercises, exercises to strengthen the diaphragm and intercostal muscles and cardiopulmonary exercises.

Sponsors & Collaborators

  • University of Rzeszow

    lead OTHER

Principal Investigators

  • Renata Borys, MSc · University of Rzeszow

  • Agnieszka Guzik, A/Prof. · University of Rzeszow

  • Magdalena Kołodziej, PhD · University of Rzeszow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-28
Primary Completion
2024-09-02
Completion
2024-10-07

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06028711 on ClinicalTrials.gov